When should you get a mammogram? Conflicting advice makes it hard to know
medicalxpress - Deciding when to get routine mammograms is confusing. Some health groups recommend women begin at age 40 or 45 while another recently opted for age 50. They also differ on whether yearly or every other year is best.
AI Summary: Conflicting guidance about when to start and how often to perform mammography continues to confuse patients and clinicians, complicating shared decision‑making. Experts urge individualized risk assessment and clearer communication of benefits and harms to reduce both undertreatment and unnecessary anxiety, because apparently screening schedules enjoy being controversial.
- Patient confusion over mammogram timing (2)
- Risk-based screening: AI and trials (3)
- USPSTF political shake-up threatens screening guidance (4)
- All Other Stories
Patient confusion over mammogram timing
Risk-based screening: AI and trials
USPSTF political shake-up threatens screening guidance
All Other Stories
Women’s experiences are forgotten in research on childbirth and breastfeeding
Thomas Saïas, Professeur de psychologie, Université du Québec à Montréal (UQAM) / theconversation - Two studies in the field of perinatal care show how, in the areas of breastfeeding and obstetrics, science prioritizes risk and the baby at the expense of mothers’ well-being.
AI Summary: New analyses show that research into childbirth and breastfeeding repeatedly sidelines women's firsthand experiences, prioritizing clinical metrics over lived realities. Experts warn this gap limits understanding of postpartum challenges, skews policy and perpetuates poorer care. Calls are growing for qualitative measures, patient-centered outcomes and inclusive study designs that actually listen to mothers.
- Clinical and policy focus on fetus over mothers' care (3)
- Mothers’ experiences ignored in childbirth and breastfeeding research (4)
- Women’s pain and reproductive conditions dismissed by medicine (4)
- All Other Stories
Clinical and policy focus on fetus over mothers' care
Mothers’ experiences ignored in childbirth and breastfeeding research
Women’s pain and reproductive conditions dismissed by medicine
All Other Stories
Sleep and diet may matter more than exercise for buffering the health toll of chronic stress
Nick Turner, Professor and Future Fund Chair in Leadership, Haskayne School of Business, University / theconversation - A 10-year study of nearly 3,000 Canadian workers finds that sleep quality and diet do more to protect health under chronic work stress than exercise.
AI Summary: New research suggests sleep quality and dietary patterns buffer the physiological harms of chronic stress more effectively than exercise alone. The findings point to prioritizing sleep and nutrition in stress mitigation programs and clinical advice, reminding clinicians and patients that the obvious — rest and real food — still matter more than the latest workout trend.
Prosecutors seek NYU hospital information on gender-affirming care for children
abcnews - A New York health care system has received a federal grand jury subpoena issued in Texas seeking information about children who received gender-affirming care and the medical providers who administered it
AI Summary: Federal prosecutors have issued a subpoena seeking NYU Langone medical records related to gender-affirming care for minors, escalating legal scrutiny of hospital practices. Authorities are pursuing documentation and communications as part of an inquiry into pediatric services; the move could prompt broader institutional reviews and legal battles over patient privacy and standards of care.
Antiviral ensitrelvir cuts risk of COVID-19 in household contacts by two-thirds, study finds
medicalxpress - The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized controlled trial published in the New England Journal of …
AI Summary: A randomized trial shows the oral antiviral ensitrelvir, used as post‑exposure prophylaxis, reduced the risk of symptomatic COVID‑19 in household contacts by roughly two‑thirds. The finding suggests a practical option for preventing spread after close exposure, offering public‑health teams a less dramatic but highly useful tool than lockdowns.
FDA clears 1st AI sepsis monitoring tool
Giles Bruce / beckershospitalreview - A tool from tech company Bayesian Health has become the first continuous AI sepsis monitor to gain FDA approval. The solution monitors hospital patients to detect deterioration and flag sepsis early on. The application was developed at Baltimore-based Joh…
AI Summary: Regulators have cleared the first AI‑driven sepsis early‑warning system for clinical deployment, enabling hospitals to use algorithmic alerts to identify patients at risk of deterioration earlier. The clearance opens the door for broader adoption of AI in acute care while renewing debates about clinical oversight, false alarms and integration into existing workflows.
License to deliver: Some midwives break the law to assist with home births
medicalxpress - In a midwife's suburban Atlanta home with a playground and chicken coop outside, Madie Collins lay on an examination table while the midwife measured her pregnant belly. Unlike at many a doctor's office, no crinkly paper sheet covered the table and no ant…
AI Summary: A growing number of midwives are reportedly supporting planned home births outside legal frameworks, knowingly operating without required licences. Regulators and health systems face a tricky balance between enforcing safety standards and meeting demand for community-based birthing options. Expect investigations, heated debates, and at least one bureaucrat suddenly very busy.
What to know about new Ebola outbreak that has killed 65 people in Congo
medicalxpress - Africa's top public health body has confirmed a new Ebola outbreak in Congo's Ituri province, the 17th since the disease first emerged in the country in 1976.
AI Summary: Health authorities have confirmed a fresh Ebola outbreak in a remote province of the Democratic Republic of Congo that has killed roughly 65 people. Public-health teams are scrambling to trace contacts, ramp up surveillance, and deploy vaccines and treatments amid logistical and security hurdles. Containment hinges on rapid mobilization and local cooperation.
- Confirmed Ituri outbreak: cases, deaths and on-the-ground response (4)
- Vaccine shortages, high lethality and push for new vaccines (3)
- WHO declares global health emergency; international response underway (4)
- All Other Stories
Confirmed Ituri outbreak: cases, deaths and on-the-ground response
Vaccine shortages, high lethality and push for new vaccines
WHO declares global health emergency; international response underway
All Other Stories
Positive VOLGA Phase III Results for Imfinzi Plus Neoadjuvant EV in MIBC
oncodaily - On May 14, 2026, AstraZeneca announced positive high-level results from a planned interim analysis of the Phase III VOLGA trial, evaluating perioperative Imfinzi with or without Imjudo in combination with […]
AI Summary: Phase III VOLGA trial results reveal that combining durvalumab (Imfinzi) with neoadjuvant enfortumab vedotin improved survival outcomes in muscle‑invasive bladder cancer. Investigators and industry voices highlight potential practice-changing implications for perioperative therapy, while stakeholders weigh regulatory filings and integration into treatment guidelines. Clinicians will want full datasets and toxicity details.
- Clinician reactions, biology and resistance concerns (4)
- Global GU oncology meetings and community coverage (3)
- VOLGA Phase III readout and regulatory landscape (3)
- All Other Stories